Schistosoma mansoni soluble egg antigens enhance HCV replication in mammalian cells

Authors

  • Mahmoud Mohamed Bahgat Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Mohamed Abd-Elhafez El-Far Division of Biochemistry , Mansura University, Mansura, Egypt
  • Ahmed Atef Mesalam Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Amany Abd-Elghany Ismaeil Clinical Pathology Department, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Ahmed Atef Ibrahim Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Hossam Eid Gewaid Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Amany Sayed Maghraby Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Mohamed Ahmed Ali Enviromental Virology Laboratory and Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt
  • Dina Nadeem Abd-Elshafy Enviromental Virology Laboratory and Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

DOI:

https://doi.org/10.3855/jidc.522

Keywords:

Schistosoma mansoni SEA, HCV replication, mammalian cells

Abstract

Background: This work demonstrates successful propagation of HCV in HepG2 and human blood cells as well as viral shedding into their culture media. The influence of Schistosoma mansoni crude soluble egg antigens (SEA) on the rate of viral propagation in both mammalian cells was also monitored.

Methodology: HepG2 cells were inoculated with HCV viremic human sera and some wells were exposed to HCV infection in presence of SEA. Cells were harvested for RT-PCR and Western blotting analysis. HepG2 media was collected for HCV ELISA. Blood samples from HCV-infected humans were cultured in the presence and absence of SEA. Media were collected at different time points post culturing and subjected to HCV ELISA.

Results: The ELISA concentration of HCV antigens were generally higher in media of infected HepG2 cells compared to media of control cells at all time intervals post infection. Western blots showed reactivity to immunogenic peptides of different molecular weights in lysate of infected HepG2 cells that were not evidenced in uninfected cells. In presence of SEA, RT-PCR results revealed earlier detection of viral RNA in infected HepG2 cells compared to in absence of such bilharzial antigen. Also, ELISA results revealed higher levels of detected HCV antigens in media of both infected HepG2 and blood cells cocultured with S. mansoni SEA compared to that of cultured infected cells in absence of the parasite antigens.

Conclusion: HepG2 cells as well as whole blood cultures maintain HCV replication. Furthermore, SEA has the potential to enhance HCV propagation.

Author Biographies

Mahmoud Mohamed Bahgat, Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Associate Professor-Therapeutic Chemistry Department, Supervisor of the Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, The National Research Center, Cairo, Egypt.

Mohamed Abd-Elhafez El-Far, Division of Biochemistry , Mansura University, Mansura, Egypt

Professor, Head of the Division of Biochemistry , Mansura University

Ahmed Atef Mesalam, Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Research Assistant-Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center-Cairo-Egypt.

Amany Abd-Elghany Ismaeil, Clinical Pathology Department, the National Research Center, Dokki, Cairo, 12311, Egypt

Researcher at the Clinical Pathology Department-the National Research Center-Cairo-Egypt.

Ahmed Atef Ibrahim, Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Research Assistant-Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center-Cairo-Egypt.

Hossam Eid Gewaid, Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Research Assistant-Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center-Cairo-Egypt.

Amany Sayed Maghraby, Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Professor-Therapeutic Chemistry Department, Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center-Cairo-Egypt.

Mohamed Ahmed Ali, Enviromental Virology Laboratory and Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Professor of Enviromental Virology-the National Research Center-Cairo-Egypt.

Dina Nadeem Abd-Elshafy, Enviromental Virology Laboratory and Immunology and Infectious Diseases Laboratory, the Center of Excellence for Advanced Sciences, the National Research Center, Dokki, Cairo, 12311, Egypt

Researcher of Enviromental Virology-the National Research Center-Cairo-Egypt.

Downloads

Published

2010-02-25

How to Cite

1.
Bahgat MM, El-Far MA-E, Mesalam AA, Ismaeil AA-E, Ibrahim AA, Gewaid HE, Maghraby AS, Ali MA, Abd-Elshafy DN (2010) Schistosoma mansoni soluble egg antigens enhance HCV replication in mammalian cells. J Infect Dev Ctries 4:226–234. doi: 10.3855/jidc.522

Issue

Section

Original Articles